Salts and solid forms of (s)- or racemic 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and methods of using the same
US-2026098035-A1 · Apr 9, 2026 · US
Celgene Corp patents
Celgene Corp holds 797 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 797 |
| Recent patents | 146 |
| First publication | Jan 1, 2015 |
| Latest publication | Apr 9, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Methods for screening cereblon modifying compounds
US-12590953-B2 · Mar 31, 2026 · US
Solid forms comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and salts thereof, and compositions comprising and methods of using the same
US-12583837-B2 · Mar 24, 2026 · US
Processes for preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-12577223-B2 · Mar 17, 2026 · US
Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof
US-2026062384-A1 · Mar 5, 2026 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Salts and solid forms of (s)- or racemic 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and methods of using the same
US-2026098035-A1 · Apr 9, 2026 · US
Methods for screening cereblon modifying compounds
US-12590953-B2 · Mar 31, 2026 · US
Solid forms comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and salts thereof, and compositions comprising and methods of using the same
US-12583837-B2 · Mar 24, 2026 · US
Processes for preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-12577223-B2 · Mar 17, 2026 · US
Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof
US-2026062384-A1 · Mar 5, 2026 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 490 |
| A61P35/02 | 250 |
| A61K45/06 | 245 |
| C07D401/04 | 212 |
| A61P43/00 | 210 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 719 |
| Chemistry & Metallurgy | 581 |
| Physics | 140 |
| Cross-Sectional Technologies | 68 |
| Operations & Transport | 18 |
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Celgene Corp have in patentsdb?
- Celgene Corp is linked to 797 publications as assignee in our database.
- What technology areas does Celgene Corp patent most?
- Top mapped technology areas by patent count: Human Necessities (719); Chemistry & Metallurgy (581); Physics (140).
- Is Celgene Corp's patent activity growing?
- In our data, assignee counts were 55 in 2024 and 45 in 2025 (lower year over year).
- What are recent patents assigned to Celgene Corp?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.